These before-and-after brain scans show improved blood flow in long COVID patients after hyperbaric oxygen therapy. [Image courtesy of Aviv Clinics]
A clinical trial involving 73 patients with long COVID has shown positive results from hyperbaric oxygen therapy (HBOT), Aviv Clinics said today.The prospective, randomized, double-blind, placebo-controlled clinical trial was published in Scientific Reports and conducted by Israel’s Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University.
“Millions of those who have recovered from COVID-19 are experiencing debilitating symptoms which persist for weeks, months or even years following their original infection,” Dr. Amir Hadanny, chief researcher and head of global clinical operations at Aviv Clinics, said in a news release. “Until today, no effective therapy has been suggested. Our research is the f…